QuantiFERON Change During Anti-tuberculosis Medication

Completed

• Conditions: Tuberculosis; Interferon-gamma Release Assay

• Registration Number: NCT01038830
• Lead Sponsor: Armed Forces Capital Hospital, Republic of Korea

Brief Summary

The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.

Detailed Description

Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.

Study Timeline

• Study Start: 2008-05
• Status Verified: 2009-12
• Study First Submitted: 2009-12-23
• Study First Submitted QC: 2009-12-23
• Study First Posted: 2009-12-24
• Primary Completion: 2010-04
• Study Completion: 2010-05
• Last Update Submitted: 2010-06-11
• Last Update Posted: 2010-06-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• All subjects with active tuberculosis

Exclusion Criteria

• Subjects who cannot complete study
• Subjects who have taken anti-tuberculosis medication for more than a month before visit of our hospital

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Armed Forces Capital Hospital; 🇰🇷 Seongnam, Gyeonggi-do, Korea, Republic of